tiprankstipranks
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
US Market

Lexicon Pharmaceuticals (LXRX) Financial Statements

Compare
1,537 Followers

Lexicon Pharmaceuticals Financial Overview

Lexicon Pharmaceuticals's market cap is currently $118.93M. The company's EPS TTM is $-0.641; its P/E ratio is ―; Lexicon Pharmaceuticals is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 31.08M$ 1.20M$ 139.00K$ 298.00K$ 24.00M
Gross Profit$ 30.46M$ 1.12M$ -288.00K$ -54.75M$ 22.07M
Operating Income$ -197.12M$ -171.75M$ -100.76M$ -87.09M$ -178.78M
EBITDA$ -184.29M$ -163.46M$ -98.74M$ -86.66M$ -41.10M
Net Income$ -200.40M$ -177.12M$ -103.13M$ -88.27M$ -70.18M
Balance Sheet
Cash & Short-Term Investments$ 237.96M$ 170.03M$ 138.36M$ 86.74M$ 152.28M
Total Assets$ 298.42M$ 229.43M$ 194.30M$ 136.91M$ 203.79M
Total Debt$ 108.40M$ 106.06M$ 55.29M$ 2.28M$ 12.81M
Net Debt$ 41.74M$ 83.60M$ 8.95M$ -61.79M$ -113.45M
Total Liabilities$ 152.47M$ 136.32M$ 77.17M$ 23.31M$ 47.42M
Stockholders' Equity$ 145.95M$ 93.11M$ -1.59B$ -1.49B$ 156.37M
Cash Flow
Free Cash Flow$ -179.81M$ -162.37M$ -90.18M$ -88.24M$ -143.06M
Operating Cash Flow$ -178.78M$ -161.90M$ -88.85M$ -87.02M$ -142.97M
Investing Cash Flow$ -15.38M$ -49.94M$ -71.08M$ 2.11M$ 380.76M
Financing Cash Flow$ 238.35M$ 187.96M$ 142.21M$ 22.71M$ -147.64M
Currency in USD

Lexicon Pharmaceuticals Earnings and Revenue History

Lexicon Pharmaceuticals Debt to Assets

Lexicon Pharmaceuticals Cash Flow

Lexicon Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis